At the moment it looks a good realignment to me, but time will tell...


"CAMBRIDGE, Mass. (June 23, 2014) - As a result of an in-depth review of the company's research & development portfolio, InVivo Therapeutics has announced that the company is realigning resources behind its novel Neuro-Spinal Scaffold and the Neuro-Spinal Scaffold Plus Stem Cells program for spinal cord injury (SCI)"..
...

"InVivo's focus will be even stronger on the company's core mission: developing meaningful treatments for spinal cord injury," CEO Mark Perrin said. "Going forward, all of the company's resources and efforts will be centered on the development of the Neuro-Spinal Scaffold for acute SCI and Scaffolds Plus Stem Cells for the treatment of chronic SCI"..

http://invivotherapeutics.cmail1.com...432AF2E34A2A5F

Paolo